Dr. Reddy's Flags Semaglutide Supply Delay After API Quality Issue
RDY is trading near its 52-week low of $12.185 (12% above the low).
Summary
Dr. Reddy's announced a quality issue with its generic semaglutide API, delaying commercial supplies. While patient safety is not impacted and existing filings remain valid, the delay is a blow to a key growth product.
Key Events · Product Development and Regulatory · RDY
-
Semaglutide API Quality Issue
Certain batches of generic semaglutide injection were found out of specification due to an issue with the active pharmaceutical ingredient (API). A root cause investigation is underway.
-
Commercial Supply Delay
Commercial supplies of semaglutide will be delayed for an unspecified period until the issue is resolved. There is no impact on patient safety or existing global regulatory filings.
-
Management Call Today
Management will host a conference call on July 9, 2026, at 16:30 IST to discuss the issue and answer questions.
-
Key Growth Product at Risk
Semaglutide is a high-value metabolic therapy; Dr. Reddy's was first to launch a generic version in Canada in May 2026. This delay could impact near-term revenue and market positioning.
Analysis · RDY · Life Sciences
A material setback for a key growth driver: Dr. Reddy's disclosed that certain batches of its generic semaglutide injection are out of specification due to an API issue, delaying commercial supplies. The company was first to launch generic semaglutide in Canada in May 2026 and recently secured U.S. exclusivity for another drug, making this delay a threat to near-term revenue from a high-value metabolic therapy. Patient safety and existing regulatory filings remain unaffected, and a root cause investigation is underway. Management will host a call today to address concerns.
At the time of this filing, RDY was trading at $13.65 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.8B. The 52-week trading range was $12.19 to $15.67. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.